I believe the efficacy results are already done and have

New Post Public Reply Private Reply Replies (2) Message Board
moxaman karateka #9745
524
I believe the efficacy results are already done and have been released by the company. We had up to a 70% improvement in biomarkers for psoriasis including inflammatory markers. These are excellent results. The IRB safety trials are either complete or about to be completed by the end of this month IMO. I'm hoping the company will compile their results and publish them. The bio-data from the trials are now protected via a USPTO patent application allowing the company to approach manufacturers for the production of our psoriasis cream. It is now "market ready" according to OWCP. Hoping to hear about distribution into the German markets any day now.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Rekor Systems Expands Roadway Intelligence with Major Contracts

Updated Category News Views 295

Rekor Systems Expands Roadway Intelligence with New Deployments Rekor Systems, Inc. (NASDAQ: REKR) has made significant strides in enhancing roadway intelligence technology through new partnerships with prominent transportation agencies. Recently, the California Department of Transportation and the Texas Department of Transportation began utilizing Rekor Discover®, a...

Continue Reading
Anticipating Targa Resources' Upcoming Earnings Report

Updated Category News Views 116

Targa Resources Earnings Report Anticipation As we approach the next earnings report for Targa Resources TRGP, investors are eager to glean insights from what is expected to be a crucial announcement. The report, scheduled for later this week, holds significant importance for market players. Projected Earnings Insights Analysts predict that Targa Resources will post an...

Continue Reading
Insider Sale Sparks Interest in BorgWarner's Future Prospects

Updated Category News Views 173

Understanding Insider Transactions at BorgWarner Recently, a notable insider sale captured attention. Isabelle McKenzie, the Vice President of BorgWarner, made headlines when she sold 2,500 shares, totaling around $100,025. This transaction was officially reported in a filing to the SEC, particularly through a Form 4. Such insider activities often spark curiosity among...

Continue Reading
FERN Group Seals Success with EUR 8 Million Bond Offering

Updated Category News Views 60

FERN Group Reaches Milestone with Public Bond Offering FERN Group, a forward-thinking provider of engineering solutions in Lithuania, has achieved an important milestone by completing a public bond offering that raised a total of EUR 8 million. Supported by the INVL Baltic Sea Growth Fund, this marks FERN's first step into the capital market, reflecting strong investor...

Continue Reading
Important Changes to Spar Nord Bank's Financial Calendar

Updated Category News Views 176

Changes to the Financial Calendar of Spar Nord Bank In a strategic move, Spar Nord Bank has aligned its financial reporting calendar with that of Nykredit Realkredit, its parent company. This decision comes in light of the Nykredit takeover of Spar Nord Bank, indicating a significant shift in how the bank plans to report its financials moving forward. The integration aims...

Continue Reading